Skip to main content
. 2019 Mar 22;8(7):e011581. doi: 10.1161/JAHA.118.011581

Figure 7.

Figure 7

Sensitivity analysis, forest plot comparing risk of incident diabetes mellitus among interventions in trials with sample sizes ≥500 patients and follow‐up ≥1 year. PCSK9 indicates proprotein convertase subtilisin/kexin type 9.